Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Le(X) and related structures as adhesion molecules.

S Hakomori1

  • 1Biomembrane Institute, Seattle, WA 98119.

The Histochemical Journal
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of b16 melanoma metastasis by administration of g(m3)- or gg3- liposomes - blocking adhesion of melanoma-cells to endothelial-cells (antiadhesion therapy) via inhibition of g(m3)-gg3cer or g(m3)-laccer interaction.

International journal of oncology·2011
Same author

P-selectin-dependent adhesion of human cancer-cells - requirement for coexpression of a psgl-1-like core protein and the glycosylation process for sialosyl-le(x) or sialosyl-le(a).

International journal of oncology·2011
Same author

Cooperative inhibitory effect of n,n,n-trimethylsphingosine and sphingosine-1-phosphate, co-incorporated in liposomes, on b16 melanoma cell metastasis - cell-membrane signaling as a target in cancer-therapy .4.

International journal of oncology·2011
Same author

Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.

International journal of oncology·2011
Same author

Inhibition of MAP kinase by sphingosine and its methylated derivative, N,N-dimethylsphingosine.

International journal of oncology·2011
Same author

Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

Advances in experimental medicine and biology·2003

Le(x) (alpha 1-->3 fucosylated type 2 chain) mediates cell adhesion and aggregation through Ca(2+)-dependent homotypic binding. Sialylated derivatives like SLe(x) and SLe(a) are key targets for selectin-mediated cell adhesion.

Area of Science:

  • Glycobiology
  • Cell Adhesion Biology
  • Developmental Biology

Background:

  • Le(x) (alpha 1-->3 fucosylated type 2 chain) is an adhesion molecule involved in Ca(2+)-mediated homotypic binding.
  • High surface expression of Le(x) leads to strong cell self-aggregation via Le(x)-Le(x) interactions.
  • This interaction plays a role in embryo compaction and F9 teratocarcinoma cell autoaggregation.

Purpose of the Study:

  • To review data supporting the concept of Le(x)-Le(x) mediated cell adhesion and aggregation.
  • To discuss the role of Le(x)-Le(x) interactions in specific biological processes.
  • To explore the function of sialylated derivatives (SLe(x), SLe(a)) in selectin-dependent adhesion.

Main Methods:

  • Review of existing scientific literature and data.

Related Experiment Videos

  • Analysis of cell aggregation assays and adhesion studies.
  • Examination of molecular structures and functional roles of carbohydrate epitopes.
  • Main Results:

    • Le(x)-Le(x) interactions drive homotypic cell binding and aggregation, potentially reinforced by other adhesion systems.
    • Sialyl Lewis x (SLe(x)) and its isomer Sialyl Lewis a (SLe(a)) are critical for selectin-mediated adhesion.
    • These sialylated epitopes are primarily found on O-linked glycoproteins, suggesting O-glycosylation inhibition as a therapeutic target.

    Conclusions:

    • Le(x) and its derivatives are crucial for various cell adhesion processes, including early development and immune cell trafficking.
    • Selectin-ligand interactions involving SLe(x) and SLe(a) are initiated by these epitopes on O-glycosylated proteins.
    • Understanding these adhesive properties is vital, especially given Le(x) abundance in the central nervous system and its changing expression patterns.